RxDoctor Payments DataLook up a doctor →

James Lilly

Emergency Medicine · Dallas, TXNPI 1356327423

Payments from drug & device makers

$8,459,659in general payments, 2019–2025

Across 7,221 payments — averaging $1171.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$5.1M
  • Eli Lilly$807K
  • Lexicon Pharmaceuticals, Inc.$726K
  • Novartis$621K
  • Braintree Laboratories, Inc.$317K
  • AstraZeneca$166K
  • plus $771K from 12 others
$55,598in research payments, 2019–2025

Across 4 payments — averaging $13,899 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$55K
  • GSK$772

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,459,659 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.

See all emergency medicine providers in Texas

Other emergency medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →